Back
EyePoint Pharmaceuticals Stock Predictions
Sell
40
EYPT
EyePoint Pharmaceuticals
Last Price:
11.14
Seasonality Move:
0.91%
7 Day Trial
ALL ACCESS PASS
$
7
EyePoint Pharmaceuticals Stock Forecast
- Over the next 52 weeks, EyePoint Pharmaceuticals has on average historically fallen by 3.9% based on the past 19 years of stock performance.
- EyePoint Pharmaceuticals has fallen lower in 11 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.89%
-
Is EyePoint Pharmaceuticals Stock Undervalued?
The current EyePoint Pharmaceuticals [EYPT] share price is $11.16. The Score for EYPT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal. - EYPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will EyePoint Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, EyePoint Pharmaceuticals has on average historically fallen by 3.9% based on the past 19 years of stock performance.
EyePoint Pharmaceuticals Stock Rating
Sell
40
EyePoint Pharmaceuticals (EYPT)
is a Sell
Is EyePoint Pharmaceuticals overpriced?
- EyePoint Pharmaceuticals has fallen lower in 11 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.89%
EyePoint Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
eyepointpharma.com
52-Week Data
52-Week High:
30.99
52-Week Low:
5.67
Prediction Charts
Market Cap:
581.26M
Price in USD:
11.16
Volume:
467.82K
Beta:
1.99
Technical Analysis
SMA50:
17.67
SMA100:
21.54
SMA200:
16.38
52-Wk Change:
77.99%
Stock Predictions
-
Is EyePoint Pharmaceuticals stock public?
Yes, EyePoint Pharmaceuticals is a publicly traded company. -
What is the EyePoint Pharmaceuticals stock quote today?
The EyePoint Pharmaceuticals stock price is 11.16 USD today. -
How to buy EyePoint Pharmaceuticals stock online?
You can buy EyePoint Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
May-7 | 11.20 | 11.87 | 11.89 | 10.65 |
May-8 | 11.87 | 11.56 | 12.30 | 11.38 |
May-9 | 12.34 | 12.67 | 12.95 | 11.75 |
May-10 | 12.80 | 12.09 | 12.90 | 11.97 |
May-13 | 12.20 | 12.22 | 12.51 | 11.94 |
May-14 | 12.49 | 12.45 | 12.96 | 12.34 |
May-15 | 12.71 | 12.94 | 13.42 | 12.68 |
May-16 | 12.90 | 12.52 | 13.04 | 12.27 |
May-17 | 12.49 | 11.84 | 12.49 | 11.81 |
May-20 | 11.84 | 12.14 | 12.33 | 11.79 |
May-21 | 12.01 | 11.59 | 12.15 | 11.44 |
May-22 | 11.70 | 11.47 | 11.83 | 11.41 |
May-23 | 11.49 | 11.11 | 11.50 | 11.01 |
May-24 | 11.11 | 11.16 | 11.42 | 10.95 |
EyePoint Pharmaceuticals Earnings
EyePoint Pharmaceuticals Earnings Report: Per Share EyePoint Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
EyePoint Pharmaceuticals Forecast Revenue Growth
EyePoint Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for EyePoint Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.85 per share.
* EyePoint Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.